US2009123422A1PendingUtilityA1

Method of treating idiopathic pulmonary fibrosis with aerosolized IFN-y

67
Assignee: NEW YORK UNIVERSITY AND THE REPriority: Dec 12, 2002Filed: Jan 13, 2009Published: May 14, 2009
Est. expiryDec 12, 2022(expired)· nominal 20-yr term from priority
Inventors:Rany CondosWilliam RomGerald Smaldone
A61K 31/56A61K 9/0078A61K 38/217A61K 38/21A61K 9/0043A61K 31/52A61K 45/06A61P 11/00A61K 31/675
67
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A method of treating idiophathic pulmonary fibrosis (IPF), comprising administering aerosolized interferon-γ in a therapeutically effective amount to achieve improved or ameliorated symptoms of IPF.

Claims

exact text as granted — not AI-modified
1 - 8 . (canceled) 
   
   
       9 . A pharmaceutical composition comprising a therapeutically effective amount of aerosolized interferon gamma for treatment of patients having IPF. 
   
   
       10 - 11 . (canceled)

Join the waitlist — get patent alerts

Track US2009123422A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.